Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity

NCT01831817 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Dentinal Hypersensitivity

Interventions

DRUG: 5% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice
DRUG: 0% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice
DRUG: Sodium monofluorophosphate dentifrice
DRUG: Sodium Fluoride dentifrice

Sponsor

GlaxoSmithKline